IA
AMPE

IFG Advisory’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

IFG Advisory’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-67
Closed -$1K – 548
2022
Q3 		$1K Hold
67
– – ﹤0.01% 517
2022
Q2 		$3K Buy
67
+33
+97% +$2.46K ﹤0.01% 460
2022
Q1 		$4K Hold
34
– – ﹤0.01% 490
2021
Q4 		$5K Buy
+34
New +$12.7K ﹤0.01% 497
2021
Q3 		– Sell
-34
Closed -$16K – 491
2021
Q2 		$16K Buy
+34
New +$18.3K ﹤0.01% 471
2021
Q1 		– Sell
-34
Closed -$16K – 493
2020
Q4 		$16K Buy
34
+1
+3% +$328 ﹤0.01% 447
2020
Q3 		$9K Buy
+33
New +$8.18K ﹤0.01% 409

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

IFG Advisory's AMPE Position: Q4 2022 in Review

IFG Advisory sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 67 shares — an estimated $1K sold.

IFG Advisory first reported a position in AMPE in Q3 2020 and held it in 7 quarters. The position peaked at $16K in Q2 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • IFG Advisory reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • IFG Advisory sold 67 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $1K.
  • IFG Advisory first reported a position in Ampio Pharmaceuticals Inc. in Q3 2020 and held it in 7 quarters.
  • IFG Advisory's Ampio Pharmaceuticals Inc. position peaked at $16K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on IFG Advisory's 13F filing for Q4 2022, filed 31 Jan 2023.